Skip to content
The People's CodeSearch
Menu

Changes to the Code

S. 4109 · Stem Cell Therapeutic and Research Reauthorization Act of 2026 ·

Reported by committee · step 2 of 5

Sections are cited like “7 U.S.C. § 2012”: 7 of the , 2012.

42 U.S.C. § 274k National Program

+2 −2Shown
More for 42 U.S.C. § 274k
Read § 274kOnly this section
3 changes the bill asks for here, 3 carried out
  1. Carried out:

    by striking Not less and inserting Beginning 1 year after the date of enactment of the Stem Cell Therapeutic and Research Reauthorization Act of 2026, not less; and

  2. Carried out:

    by striking and birthing tissues and inserting , high-quality cord blood units (as defined in section 2(h) of the Stem Cell Therapeutic and Research Act of 2005), and other emergent technologies; and

  3. Carried out:

    in paragraph (2), by striking June 30, 2025 and inserting 3 years after the date of enactment of the Stem Cell Therapeutic and Research Reauthorization Act of 2026.

§ 274k(n)–(o)

Start of § 274k to (m)(2) unchanged ·

(n) Penalties for disclosure Any person who discloses the content of any record referred to in subsection (d)(4)(D) or (f)(5)(A) without the prior written consent of the donor or potential donor with respect to whom the record is maintained, or in violation of the standards described in subsection (f)(5)(B), shall be imprisoned for not more than 2 years or fined in accordance with title 18, or both.

(o) Periodic review of state of science

(1) Review [struck: Not][inserted: Beginning] [inserted: 1 year after the date of enactment of the Stem Cell Therapeutic and Research Reauthorization Act of 2026, not ]less frequently than every 2 years, the Secretary, in consultation with the Director of the National Institutes of Health, the Commissioner of Food and Drugs, the Administrator of the Health Resources and Services Administration, the Advisory Council, and other stakeholders, where appropriate given relevant expertise, shall conduct a review of the state of the science of using adult stem cells [inserted: , high-quality cord blood units (as defined in section 2(h) of the Stem Cell Therapeutic ]and [struck: birthing][inserted: Research] [struck: tissues][inserted: Act] [inserted: of 2005), and other emergent technologies ]to develop new types of therapies for patients, for the purpose of considering the potential inclusion of such new types of therapies in the Program.

(2) Recommendations Not later than [struck: June][inserted: 3] [struck: 30,][inserted: years] [struck: 2025][inserted: after the date of enactment of the Stem Cell Therapeutic and Research Reauthorization Act of 2026], the Secretary shall—

(A) complete the second review required by paragraph (1); and

(B) informed by such review, submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives recommendations on the appropriateness of the inclusion of new types of therapies in the Program.

42 U.S.C. § 274m Authorization of appropriations

+5 −1Shown
More for 42 U.S.C. § 274m
Read § 274mOnly this section
3 changes the bill asks for here, 3 carried out
  1. Carried out:

    by striking appropriated $31,009,000 and inserting the following:(1) $31,009,000 appropriated—;

  2. Carried out:

    in paragraph (1), as so inserted, by striking the period at the end and inserting ; and; and

  3. Carried out:

    by adding at the end the following:(2) $33,009,000 for each of fiscal years 2027 through 2031..

§ 274m(1)–(2)

§ 274m. Authorization of appropriations

[inserted: For the purpose of carrying out this part, there are authorized to be appropriated—]

(1) [inserted: $31,009,000 for each of fiscal years 2022 through 2026; and]

(2) [inserted: $33,009,000 for each of fiscal years 2027 through 2031.]

[struck: For the purpose of carrying out this part, there are authorized to be appropriated $31,009,000 for each of fiscal years 2022 through 2026.]

Step through the changes